A case control study to investigate the relation between the risk of Alzheimer’s disease and exposure to benzodiazepines started at least five years before, considering both the dose-response relation and prodromes (anxiety, depression, insomnia) possibly linked with treatment.
Click here to access the full text article. You will need to login with your Athens password to view the full text article.
All Lancashire Care staff are able to register for an Athens password. Please click here to apply for an Athens password.